Importance of adherence to BCR-ABL tyrosine-kinase inhibitors in the treatment of chronic myeloid leukemia

Treatment of chronic myeloid leukemia with BCR-ABL tyrosine kinase inhibitors requires full adherence in order to maximize the likelihood of achieving optimal responses, and to minimize healthcare costs. In this article, we review some of the methods available for assessing compliance, the main cons...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: de Almeida, Maria Helena, Fogliatto, Laura, Couto, Dulce
Médium: Artigo
Jazyk:Inglês
Vydáno: Sociedade Brasileira de Hematologia e Hemoterapia 2014
Témata:
Review article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3948667/
https://ncbi.nlm.nih.gov/pubmed/24624037
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5581/1516-8484.20140014
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky